South Korea will nurture 40,000 professionals and 220 companies specialized in metaverse technology to achieve its goal of becoming the fifth largest country in the global metaverse market by 2026, the government said Thursday. The Ministry of Science and ICT announced the country’s pan-governmental strategic blueprint to lead the new industry to respond to economic and social changes that will be brought by the metaverse and prepare for the future. In particular, authorities laid out

Technology Jan. 20, 2022

As the COVID-19 pandemic forced pubs and bars to close early and limited private gatherings, more people have been drinking at home. Frantz Hotton, CEO of global wine and spirits company Pernod Ricard Group’s Korean affiliate, saw a silver lining in the virus-driven trend. “Our sales and marketing teams have made great efforts to respond well to the growing needs of off-trade market and caught up rapidly to grab opportunities in line with new drinking patterns,” Hotton said i

Consumer Jan. 20, 2022

The Korea Exchange on Tuesday announced its decision to delist biotech company SillaJen, 20 months after the biotech company’s market transactions were stopped due to breach of trust and embezzlement charges. The stock market operator will hold a Kosdaq market committee within the next 20 business days to finalize whether it will push ahead with the delisting decision or give SillaJen a second chance at revival. Although the company can raise an objection to the market committee if it o

Market Jan. 18, 2022

Started as a mere app developing company, South Korea’s platform giant Kakao has been on the fast track of success, becoming the nation‘s fifth-largest business entity just in 11 years. Founded by Kim Beom-su, who used to run a PC room and work at Samsung SDS, the dominant takeover of the messenger app KakaoTalk laid the groundwork for the Kakao group’s expansion in the last decade. According to the Korea Fair Trade Commission, Kakao had 158 affiliates and subsidiaries in the

Industry Jan. 17, 2022

Celltrion’s COVID-19 antibody treatment Regkirona has received temporary approval in Switzerland, the Korean biopharmaceutical company said Friday. Celltrion submitted the results from its global third-phase clinical trial and all clinical data on virus variants including the delta variant, according to the company. Swissmedic, which is responsible for the authorization and supervision of therapeutic products in Switzerland, gave the temporary nod Wednesday. The approval is for use Reg

Industry Jan. 14, 2022

To solidify its No. 1 position in terms of production capacity, Samsung Biologics, a contract development and manufacturing organization under the Samsung empire, will begin partial operation of its fourth plant in Songdo, west of Seoul, this year, six months earlier than previously scheduled, the company’s CEO said Thursday. Touting its manufacturing capability, John Rim, CEO of Samsung Biologics, said the planned partial operation will add fresh new capacity of 60,000 liters in October

Industry Jan. 13, 2022

AfreecaTV will aim to expand communication with global users through esports content, the Korean video streaming service said Wednesday. According to the company, AfreecaTV currently operates a total of six firms in South Korea, Japan, Taiwan, the US, Thailand and Hong Kong to provide various streaming content in different languages so that overseas users can watch it without any communication barriers. The Korean video streaming service has held a number of esports competitions abroad, with

esports Jan. 12, 2022

ABL Bio has signed a contract worth up to $1.06 billion (1.27 trillion won) with French pharmaceutical firm Sanofi to co-develop ABL301, an antibody treatment candidate for degenerative brain diseases including Parkinson’s disease, the Korean biotech company said Wednesday. ABL Bio will receive $75 million in down payments, according to the deal. The Korean biotech company will also be able to rake in up to $985 million depending on the success of clinical trials, regulatory approval and

Technology Jan. 12, 2022

Naver D2 Startup Factory has made a follow-on investment in local e-commerce data startup Datarize, the IT giant said Wednesday. Stonebridge Ventures led the series A funding of Datarize with co-investments from Weventures, Korea Development Bank and Mirae Asset Venture Investment. The total funding amounted to 11.5 billion won ($9.6 million). Naver D2 Startup Factory had previously taken part in the seed investment of Datarize in 2020. Datarize developed an all-in-one growth solution for onl

Industry Jan. 12, 2022

Hanmi Pharmaceutical will begin producing ZyCoV-D, the plasmid DNA COVID-19 vaccine developed by India’s pharmaceutical firm Zydus Cadila, starting in the second quarter of this year, the company said Tuesday. Hanmi Pharmaceutical on Friday signed a contract with local biotech company Enzychem Lifesciences for a consignment manufacturing agreement of the Indian vaccine. Previously, Enzychem Lifesciences signed a license-out deal with Zydus Cailda at the end of last year. The two Korean

Industry Jan. 11, 2022

SK Pharmteco, SK Inc.’s subsidiary of contract development and manufacturing organization, is planning for a pre-initial public offering this year, the group’s holding company SK Inc. said Tuesday.  "SK Pharmteco will hold an advantage in the global industry with its high-quality manufacturing capacity within the leading countries," said Lee Dong-hoon, SK Inc.'s executive vice president and head of the Bio Investment Center. "SK Inc. will be supporting th

Industry Jan. 11, 2022

Amid mounting criticism over Kakao executives forging a block deal to sell massive stakes they received as stock options, the IT giant’s next CEO stepped down voluntarily on Monday, leaving the company‘s management ethics in question. Ryu Young-joon, the appointee for Kakao’s next CEO, expressed his will to resign amid escalating criticism over the mass sale of his Kakao Pay shares, the IT giant said Monday. Kakao Pay is a payment platform which made a market debut in November

Industry Jan. 10, 2022

SK Inc. has invested $350 million (421.4 billion won) in the Center for Breakthrough Medicines, a Philadelphia-based cell and gene therapy firm, to become the second largest shareholder, SK Group’s holding company said Sunday. With the investment, SK Inc. has secured a strong foothold in the US cell and gene therapies market. The transaction came nine months after the holding company acquired Yposkesi, a French developer and manufacturer of cell and gene therapy products, in March. As a

Industry Jan. 9, 2022

Korean gaming giant Nexon said Thursday it has decided to invest $400 million into US production company Agbo, co-founded by Anthony and Joe Russo, the directors of Marvel’s global megahits. Through the latest investment, the Tokyo-listed Nexon plans to accelerate the global expansion of its existing and new intellectual property in the film and TV sectors, while Agbo looks to further boost its influence in the global entertainment market by strengthening its production power. Valued at

Industry Jan. 6, 2022

CJ Bioscience, a biotechnology subsidiary of CJ CheilJedang, has been officially launched with its eyes set on becoming a global leader in the microbiome sector, the Korean food giant said Wednesday. The establishment of the biotechnology firm is part of CJ Group Chairman Lee Jay-hyun’s earlier pledge to strengthen the group’s wellness business, one of the four growth engines he had vowed to cultivate for the future. CJ Bioscience on Tuesday held an inauguration ceremony with key

Industry Jan. 5, 2022